Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Standard Risk Acute Leukemia

Known as: Standard Risk, Standard Risk (MRD <0.05%) 
Acute leukemia patients are stratified into the standard risk group when their minimal residual disease levels are lower than 0.05%.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
To develop a novel acute graft-versus-host disease (GVHD) risk score, we examined the GVHD clinical stage and grade of 1723… Expand
Is this relevant?
Highly Cited
2014
Highly Cited
2014
PURPOSE From 2002 to 2007, the International Berlin-Frankfurt-Münster Study Group conducted a prospective randomized clinical… Expand
  • figure 1
  • table 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
The Children's Cancer Group enrolled 13 298 young people age <21 years on 1 of 16 protocols between 1983 and 2002. Outcomes were… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2008
2008
Despite high cure rates 25% of children with acute lymphoblastic leukaemia (ALL) relapse and have dismal outcome. Crucially, many… Expand
  • table I
  • figure 1
  • figure 2
  • table II
  • table III
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE Between September 1991 and May 1997, within the International Berlin-Frankfurt-Muenster Study Group (I-BFM-SG), a… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
The Dana-Farber Cancer Institute (DFCI) acute lymphoblastic leukemia (ALL) Consortium Protocol 91-01 was designed to improve the… Expand
  • table 1
  • table 2
  • figure 2
  • table 3
  • figure 1
Is this relevant?
2001
2001
INTRODUCTION Although definite risk classes are well known, risk-adapted modulation of first-line therapy is seldom attempted in… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1995
Highly Cited
1995
PURPOSE To assess the effect of treatment intensification and that of extended intrathecal methotrexate substitution for cranial… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
PURPOSE The goals of this treatment program were as follows: to improve event-free survival (EFS) rates for high-risk (HR… Expand
Is this relevant?
1987
1987
Six hundred and fifty-six children with acute lymphoblastic leukemia (ALL) have been diagnosed in the five Nordic countries… Expand
Is this relevant?